Le Xu

564 total citations
26 papers, 432 citations indexed

About

Le Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Le Xu has authored 26 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Le Xu's work include Renal cell carcinoma treatment (4 papers), Cancer-related gene regulation (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Le Xu is often cited by papers focused on Renal cell carcinoma treatment (4 papers), Cancer-related gene regulation (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Le Xu collaborates with scholars based in China and United States. Le Xu's co-authors include Chen Zhao, Ming Lü, Jiejie Xu, Haiou Liu, Weisi Liu, Qiang Fu, Weijuan Zhang, Deng Pan, Yu Zhu and Fang Zhao and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Medicine.

In The Last Decade

Le Xu

26 papers receiving 425 citations

Peers

Le Xu
Joseph D. Coppock United States
Antony Hsieh United States
Jia Wei China
Julio Fernandez-Banet United States
Ximao Cui China
Malorye Allison United States
Angela Hu United States
Le Xu
Citations per year, relative to Le Xu Le Xu (= 1×) peers Jieyou Zhang

Countries citing papers authored by Le Xu

Since Specialization
Citations

This map shows the geographic impact of Le Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Le Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Le Xu more than expected).

Fields of papers citing papers by Le Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Le Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Le Xu. The network helps show where Le Xu may publish in the future.

Co-authorship network of co-authors of Le Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Le Xu. A scholar is included among the top collaborators of Le Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Le Xu. Le Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Ning, Qiang Shan, Le Xu, et al.. (2024). Phenotypic Characteristics, Antimicrobial Susceptibility and Virulence Genotype Features of Trueperella pyogenes Associated with Endometritis of Dairy Cows. International Journal of Molecular Sciences. 25(7). 3974–3974. 5 indexed citations
2.
Du, Yue, Yongliang Yuan, Le Xu, et al.. (2022). Discovery of METTL3 Small Molecule Inhibitors by Virtual Screening of Natural Products. Frontiers in Pharmacology. 13. 878135–878135. 62 indexed citations
4.
Guo, Qiang, Meiyu Quan, Le Xu, et al.. (2022). Enhanced nuclear localization of YAP1‐2 contributes to EGF‐induced EMT in NSCLC. Journal of Cellular and Molecular Medicine. 26(4). 1013–1023. 8 indexed citations
5.
Li, Qingxiang, Yifei Wang, Le Xu, et al.. (2021). Oral administration of Bifidobacterium breve promotes antitumor efficacy via dendritic cells-derived interleukin 12. OncoImmunology. 10(1). 1868122–1868122. 43 indexed citations
6.
Gao, Chao, Meiyu Quan, Yuanyuan Wu, et al.. (2021). Yap1-2 Isoform Is the Primary Mediator in TGF-β1 Induced EMT in Pancreatic Cancer. Frontiers in Oncology. 11. 649290–649290. 8 indexed citations
7.
Xu, Le, et al.. (2021). The Neurotrophic Effects and Mechanism of Action for FK1706 in Neurorrhaphy Rat Models and SH-SY5Y Cells. Neurochemical Research. 46(11). 2897–2908. 1 indexed citations
8.
Wang, Yifei, Qingxiang Li, Le Xu, et al.. (2020). Cancer stemness of CD10‐positive cells regulated by Hedgehog pathway promotes the resistance to cisplatin in oral squamous cell carcinoma. Oral Diseases. 27(6). 1403–1411. 14 indexed citations
9.
Xu, Xiaoli, et al.. (2020). Knockdown of Nav1.5 inhibits cell proliferation, migration and invasion via Wnt/-catenin signaling pathway in oral squamous cell carcinoma. Acta Biochimica et Biophysica Sinica. 52(5). 527–535. 13 indexed citations
10.
Li, Qingxiang, et al.. (2020). High level of CD10 expression is associated with poor overall survival in patients with head and neck cancer. International Journal of Oral and Maxillofacial Surgery. 50(7). 857–864. 9 indexed citations
11.
Li, Xiaofeng, Biao Song, Xin Chen, et al.. (2019). Over-Expression of PTEN Suppresses the Proliferation and Migration of Fibroblast-Like Synoviocytes in Adjuvant-Induced Arthritis. Cellular Physiology and Biochemistry. 52(6). 1446–1462. 8 indexed citations
12.
Liu, Haiou, Qian Wu, Weisi Liu, et al.. (2015). ST6Gal-I Predicts Postoperative Clinical Outcome for Patients with Localized Clear-cell Renal Cell Carcinoma. Asian Pacific Journal of Cancer Prevention. 15(23). 10217–10223. 5 indexed citations
13.
Liu, Weisi, Qiang Fu, Huimin An, et al.. (2015). Decreased Expression of SETD2 Predicts Unfavorable Prognosis in Patients With Nonmetastatic Clear-Cell Renal Cell Carcinoma. Medicine. 94(45). e2004–e2004. 29 indexed citations
14.
Ye, Ting, et al.. (2015). Research on energy coordination between multi-level surge protective devices with the transmission line theory. International Journal of Applied Electromagnetics and Mechanics. 48(4). 345–356. 6 indexed citations
15.
Lv, Tao, Yanfeng Liu, Jianping Zhang, et al.. (2014). Impact of an Altered PROX1 Expression on Clinicopathology, Prognosis and Progression in Renal Cell Carcinoma. PLoS ONE. 9(5). e95996–e95996. 11 indexed citations
16.
Fu, Qiang, Zheng Liu, Deng Pan, et al.. (2014). Tumor miR‐125b predicts recurrence and survival of patients with clear‐cell renal cell carcinoma after surgical resection. Cancer Science. 105(11). 1427–1434. 23 indexed citations
17.
Zhao, Chen, Ming Lü, & Le Xu. (2014). Returns to dialect. China Economic Review. 30. 27–43. 49 indexed citations
18.
Wang, Shanshan, Yu Zhu, Hongyong He, et al.. (2013). Sorafenib suppresses growth and survival of hepatoma cells by accelerating degradation of enhancer of zeste homolog 2. Cancer Science. 104(6). 750–759. 23 indexed citations
19.
Chen, Lin, Haiou Liu, Jing Liu, et al.. (2013). Klotho Endows Hepatoma Cells with Resistance to Anoikis via VEGFR2/PAK1 Activation in Hepatocellular Carcinoma. PLoS ONE. 8(3). e58413–e58413. 38 indexed citations
20.
Xu, Le. (2013). Solution of Protection Maloperation for Zero-sequence Reactance Relay Under External High Resistance Ground Fault. Dianli xitong zidonghua. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026